DE2920500A1
(de)
*
|
1979-05-21 |
1980-11-27 |
Boehringer Sohn Ingelheim |
Pharmazeutische zubereitung in form eines polyacrylatfilmes
|
JPS57134413A
(en)
*
|
1981-02-14 |
1982-08-19 |
Nitto Electric Ind Co Ltd |
Percutaneous absorbable drug and product containing the same
|
JPS6059207B2
(ja)
*
|
1981-03-13 |
1985-12-24 |
日東電工株式会社 |
複合製剤の製法
|
JPS57150503U
(pt)
*
|
1981-03-17 |
1982-09-21 |
|
|
US4725272A
(en)
*
|
1981-06-29 |
1988-02-16 |
Alza Corporation |
Novel bandage for administering beneficial drug
|
GB2105990B
(en)
*
|
1981-08-27 |
1985-06-19 |
Nitto Electric Ind Co |
Adhesive skin patches
|
US5310559A
(en)
*
|
1982-09-01 |
1994-05-10 |
Hercon Laboratories Corporation |
Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
|
JPS5984814A
(ja)
*
|
1982-11-08 |
1984-05-16 |
Sekisui Chem Co Ltd |
薬剤徐放性製剤
|
JPS5984817A
(ja)
*
|
1982-11-08 |
1984-05-16 |
Sekisui Chem Co Ltd |
薬剤徐放性製剤
|
JPS5984813A
(ja)
*
|
1982-11-08 |
1984-05-16 |
Sekisui Chem Co Ltd |
薬剤徐放性製剤
|
GB2133284A
(en)
*
|
1983-01-07 |
1984-07-25 |
English Grains Limited |
Resilient pharmaceutical unit for treating mouth ulcers
|
US4564364A
(en)
*
|
1983-05-26 |
1986-01-14 |
Alza Corporation |
Active agent dispenser
|
FR2548021B1
(fr)
*
|
1983-06-29 |
1986-02-28 |
Dick P R |
Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
|
DE3344691A1
(de)
*
|
1983-12-10 |
1985-06-20 |
Bayer Ag, 5090 Leverkusen |
Wirkstoffabgasesysteme
|
DE3347277A1
(de)
*
|
1983-12-28 |
1985-07-11 |
Bayer Ag, 5090 Leverkusen |
Wirkstoffabgabesysteme
|
JPS60185713A
(ja)
*
|
1984-03-05 |
1985-09-21 |
Nitto Electric Ind Co Ltd |
経皮吸収性製剤及びその製法
|
EP0156080B2
(en)
*
|
1984-03-05 |
1993-10-20 |
Nitto Denko Corporation |
Percutaneous absorption type adhesive pharmaceutical preparation
|
DE3409079A1
(de)
*
|
1984-03-13 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Medizinische pflaster
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
US4725439A
(en)
*
|
1984-06-29 |
1988-02-16 |
Alza Corporation |
Transdermal drug delivery device
|
US4655768A
(en)
*
|
1984-07-06 |
1987-04-07 |
Avery International Corporation |
Bandage for sustained delivery of drugs
|
US4588580B2
(en)
*
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
US4532244A
(en)
*
|
1984-09-06 |
1985-07-30 |
Innes Margaret N |
Method of treating migraine headaches
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
US4573995A
(en)
*
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
DE3587616D1
(de)
*
|
1984-12-22 |
1993-11-11 |
Sanol Arznei Schwarz Gmbh |
Wirkstoffpflaster.
|
US4615699A
(en)
*
|
1985-05-03 |
1986-10-07 |
Alza Corporation |
Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
|
DE3518707A1
(de)
*
|
1985-05-24 |
1986-11-27 |
Beiersdorf Ag, 2000 Hamburg |
Nitro-pflaster
|
EP0252076A1
(en)
*
|
1985-12-12 |
1988-01-13 |
Flexcon Company, Inc. |
Transdermal methods and adhesives
|
US4765974A
(en)
*
|
1985-12-24 |
1988-08-23 |
Nitto Electric Industrial Co., Ltd. |
Preparation for percutaneous administration
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
DE3783683T2
(de)
*
|
1986-01-31 |
1993-05-19 |
Whitby Research Inc |
Hautpenetration verbessernde zusammensetzungen.
|
ATE71287T1
(de)
*
|
1986-06-13 |
1992-01-15 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5227157A
(en)
*
|
1986-10-14 |
1993-07-13 |
Board Of Regents, The University Of Texas System |
Delivery of therapeutic agents
|
AU610839B2
(en)
*
|
1986-11-07 |
1991-05-30 |
Purepac, Inc |
Transdermal administration of amines
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
US4830856A
(en)
*
|
1987-01-27 |
1989-05-16 |
Peppers James M |
Chelation product
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
JPH02149514A
(ja)
*
|
1988-04-06 |
1990-06-08 |
Nitto Denko Corp |
医薬部材
|
NL8801445A
(nl)
*
|
1988-06-06 |
1990-01-02 |
Dow Chemical Nederland |
Gecoextrudeerde synthetische harsstructuren en werkwijze voor de vervaardiging ervan.
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
US5026556A
(en)
*
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5324521A
(en)
*
|
1989-12-18 |
1994-06-28 |
Dermamed |
Systems for transdermal administration of medicaments
|
US5447947A
(en)
*
|
1990-02-26 |
1995-09-05 |
Arc 1 |
Compositions and methods of treatment of sympathetically maintained pain
|
US6559186B1
(en)
|
1990-02-26 |
2003-05-06 |
Arc 1, Inc. |
Compositions and methods of treatment of sympathetically maintained pain
|
US5070084A
(en)
*
|
1990-02-26 |
1991-12-03 |
Campbell James N |
Treatment of sympathetically maintained pain
|
US5508038A
(en)
*
|
1990-04-16 |
1996-04-16 |
Alza Corporation |
Polyisobutylene adhesives for transdermal devices
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
IT1251469B
(it)
*
|
1991-07-15 |
1995-05-15 |
Zambon Spa |
Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
|
JPH07503232A
(ja)
*
|
1991-10-18 |
1995-04-06 |
アルザ・コーポレーション |
メラトニンの制御経皮投与
|
WO1993023025A1
(en)
*
|
1992-05-13 |
1993-11-25 |
Alza Corporation |
Transdermal administration of oxybutynin
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
DE69401945T3
(de)
*
|
1993-06-25 |
2004-09-02 |
Alza Corp., Palo Alto |
Einarbeitung eines poly-n-vinylamids in ein transdermales system
|
DE69420419T2
(de)
*
|
1993-09-29 |
1999-12-23 |
Alza Corp |
Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
|
US5484607A
(en)
*
|
1993-10-13 |
1996-01-16 |
Horacek; H. Joseph |
Extended release clonidine formulation
|
CN1078460C
(zh)
*
|
1995-03-23 |
2002-01-30 |
北京三九克莱斯瑞控释药业有限公司 |
程控型透皮贴剂
|
US5662928A
(en)
*
|
1995-04-21 |
1997-09-02 |
Ciba-Geigy Corporation |
Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
DE19527925C2
(de)
*
|
1995-07-29 |
1997-07-03 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit einer trennmittelbeschichteten Schutzschicht
|
CA2182851A1
(en)
*
|
1995-08-15 |
1997-02-16 |
August Masaru Watanabe |
Method for treating substance abuse withdrawal
|
AU1120097A
(en)
|
1995-12-01 |
1997-06-27 |
Alza Corporation |
Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
|
US6238700B1
(en)
|
1995-12-01 |
2001-05-29 |
Alza Corporation |
Method for preventing crystal formation in a dispersion of a liquid in a matrix
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US5869089A
(en)
*
|
1996-03-21 |
1999-02-09 |
China-America Technology Corp. (Ctc) |
Manufacturing method of programmable transdermal therapeutic system
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US5985317A
(en)
*
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
GB9711032D0
(en)
*
|
1997-05-30 |
1997-07-23 |
Johnson Matthey Plc |
Compound as a stimulant for the central nervous system
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US5948433A
(en)
*
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
EP1041975B1
(en)
|
1997-12-22 |
2002-09-04 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
JP4864204B2
(ja)
*
|
1998-12-18 |
2012-02-01 |
アルザ・コーポレーション |
透明な経皮的ニコチン送達デバイス
|
EP2305324B1
(en)
*
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medical devices and applications of polyhydroxyalkanoate polymers
|
WO2001015671A2
(en)
|
1999-08-30 |
2001-03-08 |
Tepha, Inc. |
Flushable disposable polymeric products
|
CN102010324B
(zh)
|
2000-02-16 |
2014-04-02 |
布里格姆及妇女医院股份有限公司 |
阿司匹林触发的脂质介体
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
US20030013753A1
(en)
*
|
2001-06-05 |
2003-01-16 |
Ronald Aung-Din |
Transdermal migraine therapy
|
WO2003053423A2
(en)
*
|
2001-12-18 |
2003-07-03 |
The Brigham And Women's Hospital |
Inhibition or prevention of infection by bacteria with epa, dha or analogs
|
US8481772B2
(en)
|
2002-04-01 |
2013-07-09 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoid derivatives
|
US7902257B2
(en)
*
|
2002-04-01 |
2011-03-08 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoid
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
DE60330154D1
(de)
*
|
2002-08-12 |
2009-12-31 |
Brigham & Womens Hospital |
Resolvine: biotemplate zur durchführung therapeutischer anwendungen
|
WO2004078143A2
(en)
*
|
2003-03-05 |
2004-09-16 |
The Brigham And Women's Hospital Inc. |
Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
CA2525132C
(en)
*
|
2003-05-08 |
2011-06-28 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
US7439241B2
(en)
*
|
2003-05-27 |
2008-10-21 |
Galderma Laboratories, Inc. |
Compounds, formulations, and methods for treating or preventing rosacea
|
US8410102B2
(en)
|
2003-05-27 |
2013-04-02 |
Galderma Laboratories Inc. |
Methods and compositions for treating or preventing erythema
|
US20060200100A1
(en)
*
|
2003-06-18 |
2006-09-07 |
Rosati Coni F |
Method and apparatus for supplying gas to an area
|
US7014630B2
(en)
*
|
2003-06-18 |
2006-03-21 |
Oxyband Technologies, Inc. |
Tissue dressing having gas reservoir
|
WO2004112723A2
(en)
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
|
WO2005007195A1
(en)
*
|
2003-07-08 |
2005-01-27 |
Tepha, Inc. |
Poly-4-hydroxybutyrate matrices for sustained drug delivery
|
US20050020600A1
(en)
|
2003-07-23 |
2005-01-27 |
Scherer Warren J. |
Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
|
EP1663017A1
(en)
*
|
2003-08-22 |
2006-06-07 |
Tepha, Inc. |
Polyhydroxyalkanoate nerve regeneration devices
|
TWI239252B
(en)
*
|
2003-12-31 |
2005-09-11 |
Ind Tech Res Inst |
A patch and the manufacturing method of the same
|
EP1755537A4
(en)
*
|
2004-04-14 |
2009-12-09 |
Univ Boston |
METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA
|
WO2005107834A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Clawson Burrell E |
Apparatus and methods for isolating human body areas for localized cooling
|
US7611628B1
(en)
|
2004-05-13 |
2009-11-03 |
University Of Kentucky Research Foundation |
Aligned nanotubule membranes
|
US7641825B2
(en)
*
|
2004-08-03 |
2010-01-05 |
Tepha, Inc. |
Method of making a polyhydroxyalkanoate filament
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
DK2216018T3
(da)
|
2004-10-21 |
2012-07-02 |
Durect Corp |
Transdermale leveringssystemer
|
CA2596283C
(en)
*
|
2005-01-28 |
2011-11-01 |
Tepha, Inc. |
Embolization using poly-4-hydroxybutyrate particles
|
WO2007038686A2
(en)
|
2005-09-27 |
2007-04-05 |
Tissuetech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US8187639B2
(en)
*
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US8273792B2
(en)
*
|
2005-10-03 |
2012-09-25 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
|
US8026266B2
(en)
*
|
2005-11-08 |
2011-09-27 |
Arcion Therapeutics, Inc. |
Treatment of length dependent neuropathy
|
US7888422B2
(en)
|
2005-11-09 |
2011-02-15 |
Mylan Technologies Inc. |
Long-wearing removable pressure sensitive adhesive
|
JP2009515991A
(ja)
|
2005-11-18 |
2009-04-16 |
トラスティーズ オブ ボストン ユニバーシティ |
レゾルビンを使用する骨喪失の処置および防止
|
AU2006318349B2
(en)
|
2005-11-28 |
2010-08-19 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US8017598B2
(en)
|
2006-05-16 |
2011-09-13 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(−) pramipexole and methods of using the same
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
WO2008021368A2
(en)
|
2006-08-11 |
2008-02-21 |
The Johns Hopkins University |
Compositions and methods for neuroprotection
|
PL2081435T3
(pl)
|
2006-09-22 |
2016-11-30 |
|
Inhibitory kinazy tyrozynowej brutona
|
AU2007325628A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US20080152709A1
(en)
*
|
2006-12-22 |
2008-06-26 |
Drugtech Corporation |
Clonidine composition and method of use
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
US8519148B2
(en)
|
2007-03-14 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
WO2008116004A2
(en)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
KR20100020459A
(ko)
*
|
2007-06-08 |
2010-02-22 |
아드레넥스 파마슈티컬스, 아이엔씨. |
지연 방출형 제제 및 아드레날린 조절부전의 치료방법
|
US9017301B2
(en)
*
|
2007-09-04 |
2015-04-28 |
Mylan Technologies, Inc. |
Transdermal drug delivery systems comprising a coated release liner
|
RU2465272C2
(ru)
|
2007-09-10 |
2012-10-27 |
КалсиМедика, Инк. |
Соединения, моделирующие внутриклеточный кальций
|
US9775882B2
(en)
*
|
2007-09-20 |
2017-10-03 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
EP2283160A4
(en)
*
|
2008-05-07 |
2012-01-04 |
Wintherix Llc |
METHOD FOR IDENTIFYING WNT SIGNALING MODULATING COMPOUNDS IN CANCER CELLS
|
EP2309993A1
(en)
*
|
2008-06-25 |
2011-04-20 |
US Worldmeds LLC |
Skin patches and sustained-release formulations comprising lofexidine for transdermal and oral delivery
|
EP2296652B1
(en)
|
2008-06-30 |
2017-11-08 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy
|
CN102186350A
(zh)
*
|
2008-08-19 |
2011-09-14 |
诺普神经科学股份有限公司 |
使用(r)-普拉克索的组合物与方法
|
RU2472791C2
(ru)
|
2008-08-27 |
2013-01-20 |
КалсиМедика Инк. |
Соединения, модулирующие внутриклеточный кальций
|
EP2165706A1
(en)
|
2008-09-18 |
2010-03-24 |
BioAlliance Pharma |
Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
|
WO2010071866A2
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy for arthritis with tranilast
|
DK2421901T3
(en)
|
2009-04-24 |
2016-01-11 |
Tissue Tech Inc |
Compositions comprising HC-HA complex, and methods of use thereof
|
BRPI1010084A2
(pt)
*
|
2009-06-19 |
2015-08-25 |
Knopp Neurosciences Inc |
Método para tratar esclerose lateral amiotrófica em um paciente
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
EP2329849B1
(en)
|
2009-11-18 |
2015-04-29 |
Galderma Research & Development |
Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
|
US8394800B2
(en)
|
2009-11-19 |
2013-03-12 |
Galderma Laboratories, L.P. |
Method for treating psoriasis
|
JP2013518909A
(ja)
|
2010-02-08 |
2013-05-23 |
キナゲン,インク. |
アロステリックキナーゼ阻害が関係する治療方法および組成物
|
CN102884060B
(zh)
|
2010-03-24 |
2019-07-19 |
阿米泰克治疗方案公司 |
用于抑制激酶的杂环化合物
|
AU2011231544B2
(en)
|
2010-03-26 |
2015-01-15 |
Galderma Research & Development |
Improved methods and compositions for safe and effective treatment of telangiectasia
|
ES2627405T3
(es)
|
2010-03-26 |
2017-07-28 |
Galderma Research & Development |
Composiciones que comprenden brimonidina para el tratamiento del eritema
|
US11607407B2
(en)
|
2010-04-13 |
2023-03-21 |
Relmada Therapeutics, Inc. |
Dermal pharmaceutical compositions of 1-methyl-2′,6′-pipecoloxylidide and method of use
|
US20130030237A1
(en)
|
2010-04-15 |
2013-01-31 |
Charles Theuer |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
EP2563759B1
(en)
|
2010-04-27 |
2022-04-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
AU2011248877B9
(en)
|
2010-04-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
EP2563452B1
(en)
|
2010-04-28 |
2019-04-17 |
Sorrento Therapeutics, Inc. |
Composite microneedle array including nanostructures thereon
|
CA2797204C
(en)
|
2010-04-28 |
2018-06-12 |
Kimberly-Clark Worldwide, Inc. |
Device for delivery of rheumatoid arthritis medication
|
EP2563455A4
(en)
|
2010-04-28 |
2014-02-19 |
Kimberly Clark Co |
METHOD FOR INCREASING THE PERMEABILITY OF AN EPITHELIAL BARRIER
|
RU2585138C2
(ru)
|
2010-04-28 |
2016-05-27 |
Кимберли-Кларк Ворлдвайд, Инк. |
Медицинские устройства для доставки кирнк
|
US20130259875A1
(en)
|
2010-05-11 |
2013-10-03 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of amyotrophic lateral sclerosis
|
IL300955A
(en)
|
2010-06-03 |
2023-04-01 |
Pharmacyclics Llc |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-H1-pyrazolo[4,3-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1- Indicated for use as a drug to treat chronic lymphocytic leukemia or small lymphocytic lymphoma
|
AU2011293201B2
(en)
|
2010-08-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
DK2444068T4
(en)
|
2010-10-21 |
2018-03-05 |
Galderma Sa |
Brimonide sub-composition
|
US8053427B1
(en)
|
2010-10-21 |
2011-11-08 |
Galderma R&D SNC |
Brimonidine gel composition
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
KR20130108406A
(ko)
*
|
2010-11-02 |
2013-10-02 |
세키스이 메디칼 가부시키가이샤 |
첩부제
|
CN103442702B
(zh)
|
2011-01-07 |
2016-02-10 |
阿勒根公司 |
黑色素改良组合物及其使用方法
|
CN106390128B
(zh)
|
2011-01-10 |
2022-07-08 |
伊沃恩有限公司 |
β-肾上腺素能反向激动剂用于戒烟的用途
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
WO2012170905A1
(en)
|
2011-06-10 |
2012-12-13 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
EP2771059B1
(en)
|
2011-10-27 |
2019-07-17 |
Sorrento Therapeutics, Inc. |
Transdermal delivery of high viscosity bioactive agents
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
WO2013072763A2
(en)
*
|
2011-11-16 |
2013-05-23 |
Nometics Inc. |
Non-sensitizing transdermal clonidine patch
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
CA2800329A1
(en)
|
2011-12-30 |
2013-06-30 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
FR2987264A1
(fr)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
Methodes et compositions pour le traitement des metastases cancereuses
|
ES2886345T3
(es)
|
2012-03-26 |
2021-12-17 |
Golden Biotechnology Corp |
Métodos y composiciones para el tratamiento de enfermedades vasculares arterioescleróticas
|
EP3838293A1
(en)
|
2012-07-11 |
2021-06-23 |
Tissuetech, Inc. |
Compositions containing hc-ha/ptx3 complexes and methods of use thereof
|
US9895320B2
(en)
|
2012-09-28 |
2018-02-20 |
KM Transderm Ltd. |
Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
MX2015006337A
(es)
|
2012-11-21 |
2015-09-07 |
Golden Biotechnology Corp |
Metodos y composiciones para tratar enfermedades neurodegenerativas.
|
WO2014110491A1
(en)
|
2013-01-11 |
2014-07-17 |
Theratrophix Llc |
Prodrugs of treprostinil
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US10232018B2
(en)
|
2013-03-14 |
2019-03-19 |
Mallinckrodt Ard Ip Limited |
ACTH for treatment of acute respiratory distress syndrome
|
WO2014188329A2
(en)
|
2013-05-20 |
2014-11-27 |
Mylan, Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
BR112016000627B1
(pt)
|
2013-07-12 |
2022-02-08 |
Knopp Biosciences Llc |
Uso de dexpramipexol ou um sal farmaceuticamente aceitável do mesmo
|
HUE055850T2
(hu)
|
2013-08-13 |
2022-01-28 |
Knopp Biosciences Llc |
Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére
|
ES2813674T3
(es)
|
2013-08-13 |
2021-03-24 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
BR112016012728A2
(pt)
|
2013-12-05 |
2020-08-11 |
Pharmacyclics Llc |
compostos inibidores de tirosina quinase de bruton, composição farmacêutica os compreendendo e uso dos mesmos
|
CN106456595A
(zh)
|
2014-02-10 |
2017-02-22 |
帕塔拉制药有限责任公司 |
用于系统性病症的肥大细胞稳定剂治疗
|
DK3104854T3
(da)
|
2014-02-10 |
2020-05-04 |
Respivant Sciences Gmbh |
Mast-celle-stabilisatorer til lungesygdomsbehandling
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
JP6561109B2
(ja)
|
2014-07-16 |
2019-08-14 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニル誘導体化合物およびその使用方法
|
WO2016025329A1
(en)
|
2014-08-15 |
2016-02-18 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
US10485893B2
(en)
*
|
2014-11-13 |
2019-11-26 |
Sarasota Medical Products, Inc. |
Antimicrobial hydrocolloid dressing containing sequestered peroxide and preparation thereof
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
CA2969429C
(en)
|
2014-12-11 |
2020-10-27 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
BR112017018944A2
(pt)
|
2015-03-02 |
2018-05-15 |
Afgin Pharma Llc |
método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
|
CN107847526A
(zh)
|
2015-05-20 |
2018-03-27 |
组织技术公司 |
用于预防上皮细胞的增殖和上皮‑间充质转换的组合物和方法
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
AU2016317049A1
(en)
|
2015-08-31 |
2018-03-15 |
Pharmacyclics Llc |
BTK inhibitor combinations for treating multiple myeloma
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
ES2910787T3
(es)
|
2016-05-12 |
2022-05-13 |
Univ Michigan Regents |
Inhibidores de ASH1L y métodos de tratamiento con los mismos
|
WO2017205534A1
(en)
|
2016-05-25 |
2017-11-30 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
EP3504195A4
(en)
|
2016-08-26 |
2020-01-29 |
Curtana Pharmaceuticals, Inc. |
INHIBITION OF OLIG2 ACTIVITY
|
AU2017321495A1
(en)
|
2016-08-31 |
2019-03-21 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
JP2019531308A
(ja)
|
2016-10-07 |
2019-10-31 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh |
肺線維症の治療のためのクロモリン組成物
|
JP2020500882A
(ja)
|
2016-12-05 |
2020-01-16 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニルおよびその塩の皮膚投与および経皮投与方法
|
WO2019094773A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
WO2019113469A1
(en)
|
2017-12-07 |
2019-06-13 |
The Regents Of The University Of Michigan |
Nsd family inhibitors and methods of treatment therewith
|
WO2019169112A1
(en)
|
2018-02-28 |
2019-09-06 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
CN112533581A
(zh)
|
2018-06-07 |
2021-03-19 |
密歇根大学董事会 |
Prc1抑制剂及用其进行治疗的方法
|
AU2019310118A1
(en)
|
2018-07-27 |
2021-03-11 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
SG11202109899VA
(en)
|
2019-03-15 |
2021-10-28 |
Unicycive Therapeutics Inc |
Nicorandil derivatives
|
CN111035627A
(zh)
*
|
2020-01-09 |
2020-04-21 |
范小玲 |
一种可乐定透皮贴及其制备方法
|
EP4178571A4
(en)
|
2020-07-10 |
2024-07-17 |
Univ Michigan Regents |
GAS41 INHIBITORS AND THEIR METHODS OF USE
|
US11918689B1
(en)
|
2020-07-28 |
2024-03-05 |
Tris Pharma Inc |
Liquid clonidine extended release composition
|
JP7138685B2
(ja)
*
|
2020-10-26 |
2022-09-16 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニル誘導体化合物およびその使用方法
|
US20240124467A1
(en)
|
2020-12-16 |
2024-04-18 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
CA3228627A1
(en)
|
2021-08-11 |
2023-02-16 |
Thomas Butler |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
AU2022426699A1
(en)
|
2021-12-30 |
2024-07-11 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of flt3
|
GB2618810A
(en)
|
2022-05-17 |
2023-11-22 |
Novumgen Ltd |
Pharmaceutical composition for sublingual administration of clonidine
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|